Validation of novel diagnostic marker of lung squamous cell carcinoma by using detection of urinary protein fragment: a multicenter study

Not Applicable

• Conditions: ung squamous cell carcinoma

• Registration Number: JPRN-UMIN000030957
• Lead Sponsor: niversity of Miyazaki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-03-01
• Study Completion: 2020-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 190

Inclusion Criteria

Not provided

Exclusion Criteria

Patients with lung squamous cell carcinoma 1.Patients who received treatment for lung squamous cell carcinoma 2. Patients who have proteinuria, positive urine sugar or urine occult blood in urinalysis. 3.Patients who have renal dysfunction (Serum levels of creatinine > 2.0 mg/dl). 4.Patients who have current malignant neoplasm other than lung squamous cell carcinoma, or past history of malignant neoplasm within 5 years. 5.Patients who were diagnosed with other types of lung cancer (not lung squamous cell carcinoma) 6.Patients who have alcohol or drug dependence or who are suspected to have alcohol or drug dependence. 7.Patients who is pregnant or who is suspected to be pregnant. 8.Patients who was enrolled another clinical trial and was prescribed a study drug within one month. 9.Patients whose attending physicians consider to be inappropriate for this study. Patients with COPD 1.Patients who have proteinuria, positive urine sugar or urine occult blood in urinalysis. 2.Patients who have current malignant neoplasm other than lung squamous cell carcinoma, or past history of malignant neoplasm within 5 years. 3.Patients who have alcohol or drug dependence or who are suspected to have alcohol or drug dependence. 4.Patients who is pregnant or who is suspected to be pregnant. 5.Patients who was enrolled another clinical trial and was prescribed a study drug within one month. 6.Patients who were clinicaly suspected lung cancer by high resolution CT within 3 months. 7.Patients who have renal dysfunction (Serum levels of creatinine > 2.0 mg/dl). 8.Patients whose attending physicians consider to be inappropriate for this study. Healthy controls 1-5. Same criterias as COPD (1-5.) 6.Those who are current smokers or ex-smokers. 7.Those whose attending physicians consider to be inappropriate for this study.

Study & Design

• Study Type: Observational
• Study Design: Not specified